tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Y-Mabs Therapeutics (YMAB)
:YMAB
US Market
YMAB
Y-Mabs Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Y-Mabs Therapeutics (YMAB) Stock News & Sentiment

Compare
515 Followers
Promising R&D Developments and New Radiohapten Propel Y-Mabs Therapeutics to a Buy Rating
Premium
Ratings
Promising R&D Developments and New Radiohapten Propel Y-Mabs Therapeutics to a Buy Rating
1M ago
YMAB
Optimistic Outlook on Y-mAbs Therapeutics’ GD2-SADA Platform Despite Developmental Delays
Premium
Ratings
Optimistic Outlook on Y-mAbs Therapeutics’ GD2-SADA Platform Despite Developmental Delays
1M ago
YMAB
Y-Mabs Therapeutics: Buy Rating Affirmed on Promising SADA Program Advancements and Market Expansion Potential
Premium
Ratings
Y-Mabs Therapeutics: Buy Rating Affirmed on Promising SADA Program Advancements and Market Expansion Potential
1M ago
YMAB
Prolonged Development Timelines and Limited Near-Term Catalysts Lead to Sell Rating for Y-Mabs Therapeutics
Premium
Ratings
Prolonged Development Timelines and Limited Near-Term Catalysts Lead to Sell Rating for Y-Mabs Therapeutics
1M ago
YMAB
Cautious Outlook on Y-Mabs Therapeutics Due to Delayed Milestones and Early-Stage Pipeline
Premium
Ratings
Cautious Outlook on Y-Mabs Therapeutics Due to Delayed Milestones and Early-Stage Pipeline
1M ago
YMAB
Y-Mabs Therapeutics Updates on Radiopharmaceutical Progress
Premium
Company Announcements
Y-Mabs Therapeutics Updates on Radiopharmaceutical Progress
1M ago
8K
YMAB
Y-mAbs Therapeutics’ Earnings Call: Mixed Sentiment and Future Outlook
Premium
Company Announcements
Y-mAbs Therapeutics’ Earnings Call: Mixed Sentiment and Future Outlook
2M ago
YMAB
More YMAB News >

YMAB News on the Web

JonesTrading Keeps Their Buy Rating on Y-Mabs Therapeutics (YMAB)
TipRanks News
Neutral
Why Y-mAbs Therapeutics, Inc.’s (YMAB) Stock Is Down 6.80%
AAII
Neutral
Why Y-mAbs Therapeutics, Inc.’s (YMAB) Stock Is Down 5.07%
AAII
Neutral
Why Y-mAbs Therapeutics, Inc.’s (YMAB) Stock Is Up 6.09%
AAII
Neutral
Why Y-mAbs Therapeutics, Inc.’s (YMAB) Stock Is Up 5.76%
AAII
Neutral
Why Y-mAbs Therapeutics, Inc.’s (YMAB) Stock Is Down 5.58%
AAII
Neutral
Why Y-mAbs Therapeutics, Inc.’s (YMAB) Stock Is Up 5.41%
AAII
Neutral
Why Y-mAbs Therapeutics, Inc.’s (YMAB) Stock Is Up 6.24%
AAII
Neutral

News Score - Last 7 Days

Neutral
YMAB
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is YMAB’s Media Buzz Sentiment?
Currently, no data Available
What is YMAB’s weekly average amount of articles?
Currently, no data Available
What is YMAB’s News Sentiment?
59% of articles about YMAB were positive this week, compared to its sector average of 55%.
    Healthcare Stocks that are Trending in the News
    VRNAVerona Pharma
    CNCCentene
    MCKMcKesson
    OCCOrthocell Ltd
    PBYIPuma Biotechnology
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing